Home / Countries / Latvia / HIV medicines

Latvia · availability and reimbursement

HIV medicines in Latvia

Of 27 verified HIV medicine records for Latvia, 22 are available and reimbursed (81%), 3 are available but not reimbursed and 2 are not available. 15 further records are still under review.

81% of verified records reimbursed

Last checked 02/11/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 22

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Epivir, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey, Pifeltro, Prezista, Rezolsta, Symtuza, Tivicay, Triumeq, Truvada, Ziagen

Available, not reimbursed 3

Rukobia, Sunlenca, Vocabria

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 15

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Emtriva, Eviplera, Evotaz, Kivexa, Norvir, Rekambys, Retrovir, Reyataz, Stribild, Viread, Vocabria / Rekambys, Yeytuo

See every medicine with its source →

More about Latvia

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Latvia profile

Neighbouring countries

Russian FederationLithuaniaEstoniaBelarus

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.